Stay updated on Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.

Latest updates to the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check44 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated the intervention type to 'Verified 2021-09 by Apollomics Inc.' and noted that the last known status is 'Recruiting', while the previous revision (v2.13.3) has been removed.SummaryDifference3%
- Check95 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.